SCHEMBL4683209

SCHEMBL4683209

ClCc1cccc(OCCC2CC2)c1.OCc1cccc(OCCC2CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.47
ACACA Q13085 1/20 0.43
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KCNH2 Q12809 3/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
GPBAR1 Q8TDU6 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
MAOA P21397 2/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MAOB P27338 1/20 0.38
TEAD1 P28347 1/20 0.37
TEAD3 Q99594 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682048 0.93 ACACB (0.48) ACACBACACATSHRSMN1; SMN2KCNH2
SCHEMBL4682448 0.93 ACACB (0.48) ACACBACACASMN1; SMN2KCNH2PPARG
SCHEMBL16959700 0.80 TSHR (0.50) TSHRSMN1; SMN2GPBAR1CYSLTR1DRD2
SCHEMBL6241502 0.77 KDM5A (0.48) TSHRSMN1; SMN2PPARDGPBAR1CYSLTR1
SCHEMBL16902898 0.77 KDM5A (0.48) TSHRSMN1; SMN2PPARDGPBAR1CYSLTR1
SCHEMBL9859582 0.77 TSHR (0.50) TSHRSMN1; SMN2GPBAR1CYSLTR1CYP4F2
SCHEMBL18320474 0.75 ACACB (0.45) ACACBACACATSHRSMN1; SMN2MAOA
SCHEMBL16902876 0.75 TSHR (0.54) TSHRSMN1; SMN2GPBAR1CYSLTR1CYP4F2
SCHEMBL10602833 0.75 TSHR (0.54) TSHRSMN1; SMN2GPBAR1CYSLTR1CYP4F2
SCHEMBL18618135 0.74 PPARD (0.48) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910364-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2008-04-16 EP disclosed
WO-2007011833-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2007-01-25 WO disclosed